Source:http://linkedlifedata.com/resource/umls/id/C0092801
MSH: An antineoplastic agent used in the treatment of lymphoproliferative diseases including hairy-cell leukemia.,NCI: An anticancer drug that belongs to the family of drugs called antimetabolites.,CSP: adenosine deaminase-resistant congener of deoxyadenosine with selective toxicity towards lymphocytes and monocytes; used as an immunosuppressive in treating certain leukemias, lymphomas, and autoimmune disorders.,PDQ: A purine nucleoside antimetabolite analogue. Cladribine triphosphate, a phosphorylated metabolite of cladribine, incorporates into DNA, resulting in single-strand breaks in DNA, depletion of nicotinamide adenine dinucleotide (NAD) and adenosine triphosphate (ATP), and apoptosis. Because this agent is resistant to adenosine deaminase, an enzyme that inactivates some antineoplastic agents, it is selectively toxic to lymphocytes and monocytes which exhibit little deoxynucleotide deaminase activity. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=41184&idtype=1" active clinical tri